Open Beta
TREN
MetriLume
TREN

US marketsBICX

SEC-sourced researchBeta

BICX

BioCorRx Inc.

Company comparison ↗

Data passport

CIK
0001443863
Exchange
OTC
Business activity
— · SIC 8093
Financial inputs
6/6
Filing date
Sep 4, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 7,665.0000 USD; December 2025: 797,244.0000 USD797.2K USD0 USD0December 2024December 2025
BICX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20247,665.0000Mar 31, 2026
December 2025797,244.0000Mar 31, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025797,244.0000-3,440,146.0000-2,298,291.00002,147,212.000013,674,200.0000Mar 31, 2026
December 20247,665.0000-5,106,124.0000-1,096,254.0000385,941.000012,741,173.0000Mar 31, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$797.24KDecember 2025Mar 31, 202610-K
Previous period revenueRevenues$7.67KDecember 2024Mar 31, 202610-K
Net incomeNetIncomeLoss-$3.44MDecember 2025Mar 31, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$2.3MDecember 2025Mar 31, 202610-K
Total assetsAssets$2.15MDecember 2025Mar 31, 202610-K
Total liabilitiesLiabilities$13.67MDecember 2025Mar 31, 202610-K

New filings

Explore methodology ↗